McCulloch Kevin sold XERS
August 1, 2025 · Form 4 insider transaction
McCulloch Kevin sold 14,651 shares of Xeris Biopharma Holdings, Inc. at $5.38 per share, a transaction worth $78.8K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
14,651
Price
$5.38
Total value
$78.8K
InsiderMcCulloch Kevin
Role—
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateAugust 1, 2025
Filing dateAugust 4, 2025
Shares owned after1,701,159
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of August 1, 2025.; These shares include 7,225 shares that were purchased on June 30, 2025 due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan.